Evercore ISI analyst Umer Raffat initiated coverage of Metsera (MTSR) with an Outperform rating. Metsera has a full portfolio of GLP-1 ...
In a report released yesterday, Robert Coolbrith from Evercore ISI maintained a Buy rating on Magnite (MGNI – Research Report), with a price ...
Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.